Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | CNR2 | P34972 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.53 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.50 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethylaniline SCHEMBL26698928 | 1.00 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL28042549 | 0.97 | TSHR (0.64) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL17594 | 0.97 | TSHR (0.70) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL9000098 | 0.97 | TSHR (0.70) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL9638069 | 0.94 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL29597320 | 0.94 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL30880867 | 0.94 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL2215318 | 0.94 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL31229134 | 0.94 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 | |
| Diethylaniline SCHEMBL30768306 | 0.94 | TSHR (0.67) | TSHRCNR2ALDH1A1CYP3A4PSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1056 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613745-A2 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | Gilead Sciences, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| CN-119390681-A | Process for preparing COT inhibitor compounds | 吉利德科学公司 | 2025-02-07 | — | — | CN | claimed |
| US-20240150300-A1 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2024-05-09 | — | — | US | claimed |
| EP-4296266-A1 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2023-12-27 | — | — | EP | claimed |
| EP-4212533-A1 | PROCESS FOR PREPARING PURINE DERIVATIVES | Cyclacel Limited (GB) | 2023-07-19 | — | — | EP | claimed |
| US-20230104823-A1 | PROCESS FOR THE PREPARATION OF PURINE DERIVATIVES EXHIBITING CDK INHIBITORY ACTIVITY | CYCLACEL LIMITED (GB) | 2023-04-06 | — | — | US | claimed |
| EP-4126862-A1 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | GILEAD SCIENCES, INC. (US) | 2023-02-08 | — | — | EP | claimed |
| EP-3573988-B1 | PROCESS FOR PREPARING PURINE DERIVATIVES | CYCLACEL LTD (GB) | 2022-12-28 | — | — | EP | claimed |
| EP-4093740-A1 | PROCESS FOR THE PREPARATION OF PURINE DERIVATIVES EXHIBITING CDK INHIBITORY ACTIVITY | Cyclacel Limited (GB) | 2022-11-30 | — | — | EP | claimed |
| CN-115397824-A | Process for preparing COT inhibitor compounds | 吉利德科学公司 | 2022-11-25 | — | — | CN | claimed |
| EP-0979208-A4 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INT INC (US) | 2000-10-25 | — | — | EP | claimed |
| US-6124503-A | Processes for making and using alkylaminoarylcarbonyl compounds | EASTMAN KODAK COMPANY (US) | 2000-09-26 | — | — | US | claimed |
| US-6086956-A | Composition and method for reducing copper oxide to metallic copper | MORTON INTERNATIONAL INC. (US) | 2000-07-11 | — | — | US | claimed |
| EP-0979208-A1 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INTERNATIONAL, INC. (US) | 2000-02-16 | — | — | EP | claimed |
| WO-1999042402-A1 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INTERNATIONAL, INC. (US) | 1999-08-26 | — | — | WO | claimed |
| US-5900186-A | BONDING COPPER TO RESIN USING CYCLIC BORANE REDUCTING AGENT | MORTON INTERNATIONAL, INC. (US) | 1999-05-04 | — | — | US | claimed |
| EP-0680484-B1 | OPTICALLY ACTIVE BETA-AMINOALKOXYBORANE COMPLEXES | NISSAN CHEMICAL IND LTD (JP) | 1998-08-19 | — | — | EP | claimed |
| US-5753309-A | CYCLIC BORANE REDUCING AGENTS | SURFACE TEK SPECIALTY PRODUCTS, INC. (US) | 1998-05-19 | — | — | US | claimed |
| EP-0369545-B1 | PROCESS FOR THE PREPARATION OF ELEMENTAL SOLS | H.B.T. HOLLAND BIOTECHNOLOGY B.V. (NL) | 1992-08-19 | — | — | EP | claimed |
| US-4243803-A | Production of 7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid | BRISTOL-MYERS COMPANY (US) | 1981-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150300-A1 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | HDAC11, HDAC1, HDAC10 | TSHR 4094/4885CNR2 3765/4885ALDH1A1 764/4885 |
| US-20230104823-A1 | PROCESS FOR THE PREPARATION OF PURINE DERIVATIVES EXHIBITING CDK INHIBITORY ACTIVITY | CDK9, CDK19, CDK7 | TSHR 1130/4885CNR2 946/4885ALDH1A1 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.